Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
TSLA doing great this month
Check out the TeslaVision Blog at:
http://teslavisioncorp.blogspot.com/
Check this out!
www.section10419.com
I am not sure how I got on this e-mailer
I do not pay for a subscription
this appears on the bottom of the updates
good luck
If you would like to become a paid subscriber, email me at tradersprophet@gmail.com
Hey Traderlong, would you please let me know which email alert service sent you the news updates? Thanks!
hey pj
this looks good
The part I find interesting is only 4mil float
I got a flash on them this am
03-06-09
TeslaVision (TSLV:PK) $0.34 +-0.11 on 34,700 shares. This is a real gee-wiz company. It has an excellent technology for use in electronic signs. The stock has broken above all of it major Moving Averages and has little resistance to the previous high of $1.00.
Roger that Traderlong, thanks for the good intel~ I reckon we should both add some more tomalli! ;)
Looks like your charts were correct
got this in an e-mail today
03-05-09
TeslaVision (TSLV) $0.25-0.29
The company is led by a 25 year veteran of the media business and this product is focused on the media side of the business.
The signs are electro-luminescent and use only 10% of the normal energy.
There is no heat, which is a problem with most signage.
The prime customers are the casino and gaming business and the beverage sector.
There are only 4 million free trading shares in the float among a large shareholder base.
TSLV ParSAR buy signal on Friday. Above 200DMA with positive PPO and MACD. Anyone got the skivvy on this one?
Man, I'm telling ya......it is gonna get worse before it gets better. Times are getting bad. Hope all is well with you and yours. Tell the old gang I said howdy. Let Spidy know I'm still aroud.....same old email....at aol.
Hey man, you know, same thing different day. What’s with the gas prices? Spidy has this great idea of starting a new biodiesel company that makes diesel from deep fryer fat from fast food restaurants. McDonalds loss is our gain, right?
N
Now there is a blast from the past. How you doing Narcissus?
Anybody still out there?
Utek Corp · SC 13D · Manakoa Services Corp · On 11/21/07
As of November 16, 2007, UTEK was the record owner of 7,799,515 shares of common stock of Manakoa Services Company, the record owner of 95,000 shares of Series A convertible preferred stock of Manakoa Services Company that would be convertible after January 4, 2008 into approximately 126,666,667 shares of Manakoa Services Company common stock assuming that the average of the closing prices for the Manakoa Services Company common stock for the 10 trading days prior to the conversions of the stock was $.03 per share, which was the market price of the common stock on November 16, 2007. All of such shares of common stock (134,466,182 shares) would constitute approximately 72.37% of the 185,812,521 shares of common stock that would be outstanding after the conversion of such convertible preferred stock (based on the number of shares outstanding as contained in the most recently available filings with the Commission by Manakoa Services Company). UTEK has the sole power to vote and dispose of all of such shares.
http://sec.gov/cgi-bin/browse-edgar?company=UTEK&action=getcompany
http://sec.gov/cgi-bin/browse-edgar?company=&CIK=0001091967&action=getcompany
http://www.pinksheets.com/pink/quote/quote.jsp?symbol=mkos
There were 59,145,854 outstanding shares of the issuer's Common Stock on December 31, 2006.
Preferred stock, $.001 par value; 25,000,000 shares authorized,
-0- shares issued and outstanding —
Common stock, $.001 par value; 200,000,000 shares authorized,
59,145,854 shares issued and outstanding
1.02 Consideration.
In the amount of: $4,000,000 based on Convertible Preferred stock as has been approved and authorized by the board of directors of MKOS:
a) On the date of closing (“the Effective Date”) Manakoa Services Corporation (MKOS) shall acquire all 1,000 Shares of common stock of Infinite Identification Technologies, Inc, which represent all of the issued and outstanding at the date of closing, and in exchange, Manakoa Services Corporation shall issue 100,000 shares of convertible preferred stock (as described in Exhibit D of the Acquisition Agreement), of which UTEK is receiving 95% or 95,000 shares.
b) At any time after Twelve (12) months from the date of closing, UTEK shall have the option right to convert part or all its convertible preferred stock to unrestricted common stock (“Conversion Shares”) of Manakoa Services Corporation, to be adjusted to equal the amount of $3,800,000 (95% of $4,000,000) based on the previous 10 day average closing bid price on the day of conversion. For example, on the date of conversion to common, if the 10 day average closing bid price is $.10, then UTEK shall receive 38,000,000 shares of common stock in Manakoa Service Corporation. The common stock that UTEK receives shall be delivered to UTEK within 30 days of the conversion.
c) The IRREVOCABLE TRANSFER AGENT INSTRUCTIONS, attached hereto, shall be agreed to and shall instruct the Transfer Agent to effectuate UTEK’S option to convert said shares.
d) The return yield on the convertible preferred stock shall be 5% compounded quarterly, paid in cash or in-kind, and will be required to be repaid at the time of conversion by MKOS to UTEK.
e) Exchange of Stock. At the Effective Date, by virtue of the Acquisition, all of the IITI Shares that are issued and outstanding at the Effective Date shall be exchanged for 100,000 Convertible Preferred shares of MKOS (MKOS Shares, as described in Exhibit D) as follows:
To:
MKOS Convertible Preferred Shares
UTEK Corporation
95,000
Aware Capital Consultants, Inc.
5,000
100,000
1.03 Effect of Acquisition.
(a) Rights in IITI Cease. At and after the Effective Date, the holder of each certificate of common stock of IITI shall cease to have any rights as a shareholder of IITI.
(b) Closure of IITI Shares Records. From and after the Effective Date, the stock transfer books of IITI shall be closed, and there shall be no further registration of stock transfers on the records of IITI.
1.04 Closing. Subject to the terms and conditions of this Agreement, the Closing of the Acquisition shall be the date of the last executed signature affixed to this Agreement, but in no event later than January , 2007.
Can anyone tell me how to shut down a message board here on IHub? No sense in leaving this one up.....it just irks me everytime I see it in my favorites list.
looks like resistance at 100ema watching for reversal
press release
http://biz.yahoo.com/pz/070618/121514.html
Source: Advanced Medical Isotopes Corporation
Advanced Medical Isotopes Corporation Completes Purchase of the Life Sciences Division From Isonics Corporation
Monday June 18, 8:57 am ET
KENNEWICK, Wash., June 18, 2007 (PRIME NEWSWIRE) -- Advanced Medical Isotopes Corporation (AMIC) (Other OTC:ADMD.PK - News) becomes an immediate isotope provider of stable and radioactive isotopes while engaging in the development of advanced production systems and processes for bringing previously unavailable medical isotopes to the marketplace, has completed the purchase of the Life Sciences division of Isonics for $850,000. The Life Sciences division of Isonics (see http://www.isonics.com) has had profitable sales of over $5,000,000 over the past two fiscal years.
With the Life Sciences purchase, AMIC gains a re-seller arrangement and extensive business acumen, along with scientific relationships via the USIC- IPP program with two major suppliers of isotopes in Russia, as well as a commercial arrangement with Central Radiopharmaceutical Services, utilizing the 30 MEV cyclotron at the State University of New York at Buffalo. AMIC now immediately gains production capability and instant commercial entry into the emerging markets of Indium-111, Actinium-225, Oxygen-18, as well as the four major PET isotopes, and importantly, current customers varying from radiopharmacies, to Universities and leading Research Centers, as well as several leading hospitals across the nation.
``We understand the extraordinary growth of U.S. demand for medical imaging products will reach $21.4 billion by 2010, and AMIC is positioning itself to take full advantage of that growth. Nuclear medicine, for both diagnosis and therapeutic purposes is growing at double-digit rates. Furthermore, both China and India are experiencing tremendous growth curves utilizing medical isotopes, and we are exploring strategic relationships with other companies involved in those geographic areas,'' stated William J. Stokes, CEO.
AMIC anticipates expanding the sales of major diagnostic Indium-111, therapeutic medical isotopes Actinium/Bismuth -213 as well as Oxygen-18 (used in PET) and further rapid expansion into the production of other high margin medical isotopes, by fully deploying the marketing personnel of the Life Sciences unit in conjunction with the tutelage from the Chief Science Officer. Isotopes produced by AMIC uniquely positions the company to utilize its first linear accelerator machine in Kennewick, Washington (as well as using the 30 MEV cyclotron in New York) to license and joint venture with Universities, Research Centers and hospitals, and the United States National Laboratories, as well as commercial arrangements with radiopharmaceutical companies for the treatment and diagnosis of diseases.
Chief Science Officer Dr. Robert Schenter said, ``The dozens of isotopes that AMIC expects to produce will assist new areas of research and treatment that have not been achievable without our cost-effective proprietary technology.''
About AMIC
Advanced Medical Isotopes Corporation is engaged in the development of advanced production systems and processes for bringing previously unavailable medical isotopes to the marketplace and advancing systems for local product production. The field of nuclear medicine has routinely utilized radioisotopes in the diagnosis of disease while new processes are being pioneered for the targeted treatment of diseases such as cancer in preference to surgical techniques. Advanced Medical Isotopes Corporation products support the accessibility to these less invasive therapeutic processes by advancing systems for lower cost production and improving supply availability of medical isotopes to hospitals and clinical treatment centers. For more information, please visit http://www.advancedmedicalisotopes.com.
Forward-Looking Statements
Except for historical information contained herein, the matters set forth in this press release, such as statements relating to the company's ability to drive technological developments and the acceptance and timing of product introductions, are forward-looking statements that are subject to risks and uncertainties, including but not limited to, timely development and acceptance of new products, the impact of competitive products and pricing, the timely development and release of products by suppliers, and other risks.
Contact:Advanced Medical Isotopes Corporation
James C. Katzaroff
(509) 736-7000
Fax: (509) 736-7001
--------------------------------------------------------------------------------
Source: Advanced Medical Isotopes Corporation
MKOS.PK
can it be?.... again?....
the pinksheets?.... batting 1000 aren't you slugger?....
http://finance.yahoo.com/q?s=mkos
manakoa closed Friday at 3 cents today and Jim's secret isotope company ADMD.PK closed at 83 cents....
shows you where his loyalties lie....
watch.... Katzaroff will probably find a way to blame it on Dr. Williams....
press release
http://biz.yahoo.com/pz/070517/119761.html
Advanced Medical Isotopes Corporation Joins U.S. Industry Coalition
Thursday May 17, 9:32 am ET
KENNEWICK, Wash., May 17, 2007 (PRIME NEWSWIRE) -- Advanced Medical Isotopes Corporation (AMIC) (Other OTC:ADMD.PK - News) announced that as an integral part of its 2007 Corporate Growth Strategy, the company recently joined the U.S. Industry Coalition (USIC).
USIC (http://www.USIC.net)) is a nonprofit organization of American businesses, associations, and research institutions dedicated to the nonproliferation of weapons of mass destruction through technology commercialization. USIC builds partnerships by bringing together U.S. companies with scientists and engineers in emerging Eurasian markets and has facilitated business ventures worth hundreds of millions of dollars.
AMIC, as Lead Partner, has jointly submitted an International Proliferation Prevention (IPP) proposal to the U.S. Department of Energy (DOE) for the development of an advanced compact Neutron Generator system for development by the Kharkiv Institute of Physics and Technology (KIPT) in the Ukraine, which utilizes cold war technology developed for neutron based weapons. The technology utilizes a Linear Proton Accelerator to focus a proton beam on a Beryllium sphere to generate a directionally controlled neutron particle beam. This technology produces a higher energy flux over a focused area for high yield isotope production, and indicates a process that may be a technically superior process to any current commercially available production system.
The IPP is expected to be an 18 to 24 month project and will be conducted with an internationally recognized engineering team partner (ARES Corporation) and the Pacific Northwest National Laboratory, providing AMIC with the Intellectual Property rights for this technology utilization in all countries outside the former Soviet Union.
CEO William J. Stokes, said: ``This project further expands AMIC's intellectual property portfolio for the production of medical and diagnostic radioisotopes and we anticipate a bright future for the commercialization of this technology.''
About AMIC
Advanced Medical Isotopes Corporation is engaged in the development of advanced production systems and processes for bringing previously unavailable medical isotopes to the marketplace and advancing systems for local product production. The field of nuclear medicine has routinely utilized radioisotopes in the diagnosis of disease while new processes are being pioneered for the targeted treatment of diseases such as cancer in preference to surgical techniques. Advanced Medical Isotopes Corporation products support the accessibility to these less invasive therapeutic processes by advancing systems for lower cost production and improving supply availability of medical isotopes to hospitals and clinical treatment centers. For more information, please visit http://www.advancedmedicalisotopes.com
Forward-Looking Statements
Except for historical information contained herein, the matters set forth in this press release, such as statements relating to the company's ability to drive technological developments and the acceptance and timing of product introductions, are forward-looking statements that are subject to risks and uncertainties, including but not limited to, timely development and acceptance of new products, the impact of competitive products and pricing, the timely development and release of products by suppliers, and other risks.
Contact: Advanced Medical Isotopes Corporation
James C. Katzaroff
(509) 736-7000
Fax: (509) 736-7001
--------------------------------------------------------------------------------
Source: Advanced Medical Isotopes Corporation
press release
looks like Katzaroff's pet company is doing well....
err.... i mean.... the other company....
http://biz.yahoo.com/pz/070517/119761.html
Advanced Medical Isotopes Corporation Joins U.S. Industry Coalition
Thursday May 17, 9:32 am ET
KENNEWICK, Wash., May 17, 2007 (PRIME NEWSWIRE) -- Advanced Medical Isotopes Corporation (AMIC) (Other OTC:ADMD.PK - News) announced that as an integral part of its 2007 Corporate Growth Strategy, the company recently joined the U.S. Industry Coalition (USIC).
USIC (http://www.USIC.net)) is a nonprofit organization of American businesses, associations, and research institutions dedicated to the nonproliferation of weapons of mass destruction through technology commercialization. USIC builds partnerships by bringing together U.S. companies with scientists and engineers in emerging Eurasian markets and has facilitated business ventures worth hundreds of millions of dollars.
AMIC, as Lead Partner, has jointly submitted an International Proliferation Prevention (IPP) proposal to the U.S. Department of Energy (DOE) for the development of an advanced compact Neutron Generator system for development by the Kharkiv Institute of Physics and Technology (KIPT) in the Ukraine, which utilizes cold war technology developed for neutron based weapons. The technology utilizes a Linear Proton Accelerator to focus a proton beam on a Beryllium sphere to generate a directionally controlled neutron particle beam. This technology produces a higher energy flux over a focused area for high yield isotope production, and indicates a process that may be a technically superior process to any current commercially available production system.
The IPP is expected to be an 18 to 24 month project and will be conducted with an internationally recognized engineering team partner (ARES Corporation) and the Pacific Northwest National Laboratory, providing AMIC with the Intellectual Property rights for this technology utilization in all countries outside the former Soviet Union.
CEO William J. Stokes, said: ``This project further expands AMIC's intellectual property portfolio for the production of medical and diagnostic radioisotopes and we anticipate a bright future for the commercialization of this technology.''
About AMIC
Advanced Medical Isotopes Corporation is engaged in the development of advanced production systems and processes for bringing previously unavailable medical isotopes to the marketplace and advancing systems for local product production. The field of nuclear medicine has routinely utilized radioisotopes in the diagnosis of disease while new processes are being pioneered for the targeted treatment of diseases such as cancer in preference to surgical techniques. Advanced Medical Isotopes Corporation products support the accessibility to these less invasive therapeutic processes by advancing systems for lower cost production and improving supply availability of medical isotopes to hospitals and clinical treatment centers. For more information, please visit http://www.advancedmedicalisotopes.com
Forward-Looking Statements
Except for historical information contained herein, the matters set forth in this press release, such as statements relating to the company's ability to drive technological developments and the acceptance and timing of product introductions, are forward-looking statements that are subject to risks and uncertainties, including but not limited to, timely development and acceptance of new products, the impact of competitive products and pricing, the timely development and release of products by suppliers, and other risks.
Contact: Advanced Medical Isotopes Corporation
James C. Katzaroff
(509) 736-7000
Fax: (509) 736-7001
--------------------------------------------------------------------------------
Source: Advanced Medical Isotopes Corporation
this is from the most recent annual report....
http://www.qurl.com/krws6
http://www.qurl.com/lk45k
ITEM 9 - LEGAL PROCEEDINGS
On January 16, 2006, Edward Nichols, a former employee, filed suit in Boulder County, Colorado against the Company and its Board of Directors claiming default on a note he holds with the company for $100,000 for purported past services while with Secure Logistix Corporation. Also included in the suit were demands for past wages and expenses while employed by the Company.
On September 25, 2006, a Stipulation for Judgment was entered into among the Company and Mr. Nichols. Mr. Nichols was awarded a judgment in the principal amount of $49,416, a statutory penalty of $24,708 and attorney fees of $9,170 for a total judgment of $83,294 on the wage claim cause of action. The Company agreed to pay Mr. Nichols $49,416 in quarterly installments of $12,354 on September 29, 2006, December 29, 2006, March 29, 2007 and June 29, 2007. The Company also agreed to deliver 250,000 shares of Manakoa’s common stock to Mr. Nichols. The Company made the initial payment under the judgment prior to September 29, 2006 and issued the 250,000 shares subsequent to September 30, 2006.
In return for the payment of $49,416 and the delivery of the 250,000 shares of Manakoa’s common stock, Mr. Nichols agreed that execution shall be stayed on the wage claim judgment. If the Company makes all payments in a timely manner, the judgment of $83,294 shall be vacated. The balance owed on the judgment as of December 31, 2006, totaling $24,708, is included in the accompanying financial statements as Judgment payable.
Mr. Nichols shall be entitled to a judgment on the promissory note cause of action in the amount of $100,000 plus interest, and agrees that execution of the aforementioned note shall be stayed until June 30, 2008, should the Company be successful in its arbitration case, on or before June 30, 2008, if the company is successful in obtaining a judgment against ex-CEO and director Robert Williams and others represented as consultants, employees and founders of Secure Logistix (see below). The $100,000 principal balance owed as of December 31, 2006 is included in the accompanying financial statements as part of Notes payable, other. The balance owed for accrued interest as of December 31, 2006, totaling $24,773, is included in the accompanying financial statements as Accrued interest payable, other.
On May 5, 2006, the Company received from former employee Jon Foucault a demand letter regarding a demand promissory note dated December 30, 2004, in the original amount of $25,000 due him by the Company.
On or about November 1, 2006, the Company filed a Notice of Intent to Arbitrate naming ex-CEO Robert Williams, ex-VP Software Development Tony Noblett, ex-VP Platform Architecture Mark Walla, ex-VP Business Development Edward Nichols, and former employees and consultants Ellen Gardner and Jeremiah Beckett. All parties listed are third party beneficiaries, receiving benefits from the Stock Purchase Agreement between Manakoa, Secure Logistix, and Williams.
Manakoa intends to arbitrate full restoration of the parties, including those named third party beneficiaries, to their original position prior to entry of the Stock Purchase Agreement, including restoration of all assets and return of all issued and outstanding stock of Manakoa from all parties to the contract, including the named third party beneficiaries, as well as cancellation of the notes to all parties to the contract, including the named third party beneficiaries. Manakoa further intends to arbitrate all claims of material breach and material misrepresentation and the damages related there from by Mr. Williams and Secure Logistix to Manakoa. Manakoa further intends to arbitrate all issues of self-dealing, fraud, tortious interference with business expectancy by virtue of the conduct by Mr. Williams, individually, as a shareholder, past CEO, and director of Manakoa and a shareholder and director of Secure Logistix.
ADMD ceo on wall street reporter....
http://www.wallstreetreporter.com/profile.php?id=23768
No problem. He can just print some more.
Utek Corp dumping MKOS shares....
i guess they don't love Katzaroff anymore....
http://finance.yahoo.com/q/it?s=MKOS.OB
ADMD to apply for OTCBB listing....
too bad Katzaroff is not working so hard for Manakoa....
http://biz.yahoo.com/pz/070402/116601.html
Advanced Medical Isotopes Corporation to Apply for OTC:BB Listing
Monday April 2, 9:46 am ET
KENNEWICK, Wash., April 2, 2007 (PRIME NEWSWIRE) -- Advanced Medical Isotopes Corporation (AMIC) (Other OTC:ADMD.PK - News) announced that as part of its 2007 Corporate Growth Strategy, the company intends to apply for listing on the Over-The-Counter Bulletin Board (OTCBB:BB.OB-NEWS) during 2007.
A listing on the OTC:BB should provide the company's shareholders greater liquidity, increased exposure and greater transparency of the company's operations, as well as increased access to capital markets.
CEO William J. Stokes commented, ``Moving from the Pink Sheets to the Over-The-Counter Bulletin Board is certainly an arduous undertaking, nevertheless, we anticipate to meet this objective while creating additional value for our stakeholders. With our aggressive corporate growth strategy, it is essential to move the company to a higher listing.'
About AMIC
Advanced Medical Isotopes Corporation is engaged in the development of advanced production systems and processes for bringing previously unavailable medical isotopes to the marketplace and advancing systems for local product production. The field of nuclear medicine has routinely utilized radioisotopes in the diagnosis of disease while new processes are being pioneered for the targeted treatment of diseases such as cancer in preference to surgical techniques. Advanced Medical Isotopes Corporation products support the accessibility to these less invasive therapeutic processes by advancing systems for lower cost production and improving supply availability of medical isotopes to hospitals and clinical treatment centers. For more information, please visit http://www.advancedmedicalisotopes.com
Forward-Looking Statements
Except for historical information contained herein, the matters set forth in this press release, such as statements relating to the company's ability to drive technological developments and the acceptance and timing of product introductions, are forward-looking statements that are subject to risks and uncertainties, including but not limited to, timely development and acceptance of new products, the impact of competitive products and pricing, the timely development and release of products by suppliers, and other risks.
Contact: Advanced Medical Isotopes Corporation
James C. Katzaroff
(509) 736-7000
Fax: (509) 736-7001
--------------------------------------------------------------------------------
Source: Advanced Medical Isotopes Corporation
ADMD under scrutiny....
http://qurl.com/b9mc8
ADVANCED MEDICAL ISOTOPE CORP
Pinnacle Digest: Memorandum Signed Spurs Review: Sector Specific
3/28/2007
Mar 28, 2007 (M2 PRESSWIRE via COMTEX News Network) --
To read this article in its entirety, visit www.pinnacledigest.com.
Advanced Medical Isotopes Corporation (OTC:PK:ADMD) experienced a significant loss in share value Tuesday, falling 12.50% along with 66,130 shares traded. They recently announced the signing of a Memorandum of Understanding with Kadlec Medical Center as a precursor step to formal contract discussions for the supply of short-lived radio-isotopes primarily used in Positron Emission Tomography(PET) and other diagnostic imaging applications. This has spurred a progressive review by PinnacleDigest. We are closely reviewing this company's recent news in respect to the major movements within the healthcare sector. To read this article in full and to learn more about our expanding, diverse online financial magazine, visit us at www.pinnacledigest.com.
The IT side of managing and delivering healthcare has emerged to the forefront of the healthcare industry and will guide its future advancement. InnerWireless and PanGo Networks announced last week their merger. Both of these company's hold major stakes in the healthcare IT market. This is a trend that is sweeping the country and world as hospitals and healthcare institutions are adapting to make operations efficient.
InnerWireless provides wireless coverage inside large buildings, most notably hospitals and commercial and government facilities. They have also recently launched Spot, a real-time tracking system that keeps track of hospital assets, patients and staff.
California's stem cell agency is in the news after awarding 29 research grants totaling a colossal $74.6 million to non-profit California institutions and universities. As the world progresses with stem cell research, the state of California is the single largest source of funds for embryonic stem-cell research in the world. A company based out of Baltimore, Osiris Therapeutics has recently been in the news documenting their easy to administer stem cell treatment in respect to heart attack patients. After a recent study the treatment reportedly helped patients recover after a heart attack as well as easing their symptoms. This company is moving forward in this area, intending to conduct studies of adult stem cell-based products to treat diseased hearts. PinnacleDigest will be reviewing the issue and coming back to the major grants awarded documenting the companies involved and the overall potential created by these grants.
Let's turn back to Advanced Medical Isotopes Corporation and learn more about their recently signed memorandum. The CEO of Advanced Medical Isotopes William Stokes had this to say following the announcement, "This arrangement with Kadlec Medical Center as our anchor customer is a fantastic opportunity for our company and our local area for the continued development of a Tri-Cites based isotope industry. We want to expressly thank Kadlec's willingness to support a local company and allows AMIC to continue our agenda for the utilization of the vast knowledge and expertise in our scientific community." PinnacleDigest will be awaiting further corporate developments from this company as well as the integration of this new factor. To follow up with Advanced Medical Isotopes and learn more about the sector influencing this company, come explore our expanding, diverse online financial magazine at www.pinnacledigest.com.
To continue with this report as well as other related articles, please visit www.pinnacledigest.com for a complimentary membership. It should be stated that our membership requires no commitment to our service. If you would like to contact us please write to support@pinnacledigest.com.
PinnacleDigest has no vested interest in the company mentioned herein. This source of information is from an unbiased perspective. If you wish to become a member of www.pinnacledigest.com you will be gaining access to articles similar to this one and many other useful services we know you will find valuable. Keeping you educated and up-to-date with the market is one of our main purposes. Our approach in achieving this goal and our ability to consistently deliver high quality investment material is what defines our business model.
Investors seeking a distinctive approach to investing should also visit www.pinnacledigest.com for a complimentary membership.
About Pinnacle Digest
Pinnacledigest.com is an emerging online financial newsletter community. We put together informative material, capturing the information that we know will give you an edge to your portfolio and more specifically your investment approach.
Once a member of PinnacleDigest you will be able to access our complimentary full-length research reports on selected companies, our weekly volumes, and our market overviews. In addition to these services we are confident you will enjoy our many other services, as well as our main feature which is available to all our members.
We pride ourselves in having a multi purpose online magazine and encourage you to join our community.
This news release shall not constitute an offer to sell or the solicitation of any offer to buy securities in any jurisdiction.
All material herein was prepared by Pinnacledigest.com (Pinnacle Digest) based upon information believed to be reliable. The information contained herein is not guaranteed by Pinnacledigest.com to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Pinnacledigest.com is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. Pinnacledigest.com may receive compensation in cash or shares from independent third parties or from the companies mentioned.
Pinnacledigest.com will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and Pinnacledigest.com undertakes no obligation to update such statements.
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
(C)1994-2007 M2 COMMUNICATIONS LTD
Worldwide exclusive licence
UTEK Corporation Completes Technology Transfer With Manakoa Services Corporation
2007-01-08 02:00 ET - News Release
Transfer Includes Worldwide Exclusive License to a Unique RFID Technology
Company Website: http://www.utekcorp.com
TAMPA, Fla. & KENNEWICK, Wash. -- (Business Wire)
UTEK Corporation (AMEX:UTK) (LSE-AIM:UTK) a specialty finance company focused on technology transfer, and Manakoa Services Corporation (OTCBB:MKOS), a company focused on global security technology products, are pleased to announce today that Manakoa Services Corporation has acquired Infinite Identification Technologies, Inc., a subsidiary of UTEK Corporation, in a stock transaction.
Infinite Identification Technologies, Inc. possesses a worldwide exclusive license for a reflective wireless technology for RFID and remote sensor applications. The technology was originally developed by a federal research laboratory for the U.S. Department of Defense for covert communication operations and is now declassified. It is designed to utilize modulated-reflectance technology to enhance radio frequency identification tracking systems and sensors.
“This technology could potentially eliminate the need for a microchip or battery in radio-frequency identification (RFID) tags,” said Paul Reep, President of Manakoa Services. He added, “All parts of this new RFID and antennae can be printed with conductive inks, potentially reducing the costs per tag compared with other RFID tags on the market today. We believe this technology could help address the need for cost-effective tracking and monitoring of products.”
“UTEK is pleased to consummate this technology transfer with Manakoa Services Corporation,” said Joel Edelson, Vice President of Technology Licensing at UTEK Corporation.
About Manakoa Services Corporation
Manakoa is a development stage company with the mission to become a leader in global security technology products to detect and interdict criminal activity in counterfeiting, product diversion and intellectual property theft. Manakoa seeks to market a variety of technologies that it owns, licenses or resells, providing a technology menu that addresses a wide range of needs in the marketplace. For more information about Manakoa Services Corporation, please visit its website at www.manakoa.com.
About UTEK Corporation
UTEK® is a specialty finance company focused on technology transfer. UTEK’s services enable companies to acquire innovative technologies from universities and research laboratories worldwide. UTEK facilitates the identification and acquisition of external technologies for clients in exchange for their equity securities. This unique process is called U2B®. In addition, UTEK offers companies the tools to search, analyze and manage university intellectual properties. UTEK is a business development company with operations in the United States, United Kingdom and Israel. For more information about UTEK, please visit its website at www.utekcorp.com.
Forward-Looking Statements
Certain matters discussed in this press release are "forward-looking statements." These forward-looking statements can generally be identified as such because the context of the statement will include words, such as UTEK or Manakoa Services Corporation "expects," "should," "believes," "anticipates" or words of similar import. Similarly, statements that describe UTEK's or Manakoa Services Corporation’s future plans, objectives or goals are also forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties, including the financial performance of UTEK or Manakoa Services Corporation, as appropriate, and the valuation of UTEK's investment portfolio, which could cause actual results to differ materially from those currently anticipated. Although UTEK and Manakoa Services Corporation believe the expectations reflected in any forward-looking statements are based on reasonable assumptions, they cannot give any assurance that their expectations will be attained. Shareholders, potential investors and other readers are urged to consider these factors carefully in evaluating any forward-looking statements. Certain factors could cause results and conditions to differ materially from those projected in these forward-looking statements, and some of these factors are discussed below. These factors are not exhaustive. New factors, risks and uncertainties may emerge from time to time that may affect the forward-looking statements made herein. These forward-looking statements are only made as of the date of this press release and both UTEK and Manakoa Services Corporation do not undertake any obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.
UTEK's operating results could fluctuate significantly due to a number of factors. These factors include the small number of transactions that are completed each quarter, the value of individual transactions, the timing of the recognition and the magnitude of unrealized gains and losses, UTEK's dependence on the performance of companies in its portfolio, the possibility that advances in technology could render the technologies it has transferred obsolete, the loss of technology licenses by companies in its portfolio, the degree to which it encounters competition in its markets, the volatility of the stock market and the volatility of the valuations of the companies it has invested in as it relates to its realized and unrealized gains and losses, the concentration of investments in a small number of companies, as well as other general economic conditions. As a result of these and other factors, current results may not be indicative of UTEK's future performance. For more information on UTEK and for a more complete discussion of the risks pertaining to an investment in UTEK, please refer to UTEK's filings with the Securities and Exchange Commission.
Contacts:
UTEK Corporation, Tampa
Tania Bernier (USA), 813-754-4330 x 223
or
Consulting for Strategic Growth 1
Stan Wunderlich, 800-625-2236
or
Bankside Consultants (UK)
Steve Liebmann or Simon Bloomfield, + 44 (0) 20-7367-8883
or
Manakoa Services Corporation
James C. Katzaroff, 509-736-7000
Source: UTEK Corporation
Manakoa Security and Advanced ID Corporation Announce a Joint Marketing and Technology Integration Agreement On DNA and RFID
KENNEWICK, Wash., Sept. 27, 2006, Sep 27, 2006 (PRIMEZONE via COMTEX) -- Manakoa Services Corporation ( MKOS ), a security technology company with anti-counterfeiting DNA, optical marker, tag and trace products to enhance security, has announced a technology and sales partnership with Advanced ID Corporation ( AIDO ), a radio frequency identification (RFID) technology provider.
The companies will cross-market their technologies to provide a fully integrated product authentication and supply chain integrity system linking Manakoa's DNA forensic authentication of primary packaging labels, papers and inks, with Advanced ID's advanced RFID of packaging and cartons. Target industries for the new partnership include pharmaceuticals, beauty products, automotive and tires, fine art and collectibles, bio-security, food safety and shipping.
Chris Outwater, President of Manakoa, said, "This is the first marriage of molecular biology at the fundamental DNA level with radio frequency identification to ensure security in the supply chain. By combining these cutting edge technologies, we can provide multi-layered, seamless security to ensure product integrity and validity."
Dan Finch, President & Chief Executive Officer of Advanced ID said, "Our ultra high frequency (UHF) RFID technology offers increased data transfer speed, extended read range, comparable pricing to bar code tags and unparalleled reliability in harsh operating environments. Extending our reach into product and packaging identification with DNA molecular security is a next generation advance for our high technology RFID product line."
About Manakoa Services Corporation
Manakoa Services Corporation ( MKOS ) develops and supplies DNA marking and optical security technology for high value products and brands that are under siege from counterfeiters. Manakoa's innovative products authenticate products from manufacture to final sale with advanced optical market, tag and trace technologies. Through licensing arrangements and partnerships with other security companies, Manakoa is able to offer a comprehensive portfolio of authentication and security products that link to its core DNA technology.
About Advanced ID Corporation
Advanced ID Corporation ( AIDO ) is a complete solutions provider in the radio frequency identification (RFID) market. Since 1994, Advanced ID Corporation has been offering a Low Frequency (LF) product line of over 100 RFID microchips and identification scanners, as well as proprietary recovery databases. Advanced ID is also a leader in UHF-RFID technology with its line of DataTRAC(tm) livestock tracking and traceability products, and UHF-RFID automotive tire tag applications.
Safe Harbor Statement:
Statements in this press release other than statements of historical fact, including statements regarding the company's plans, beliefs and estimate as to projections are "forward-looking statements." Such statements are subject to certain risks and uncertainties, including factors listed from time to time in the company's SEC filings, and actual results could differ materially from expected results. These forward-looking statements represent the company's judgment as of the date of this release.
This news release was distributed by PrimeZone, www.primezone.com
SOURCE: Manakoa Services Corporation; Advanced ID Corporation
Manakoa Services Corporation
James C. Katzaroff, Chief Executive Officer
(509) 736-7000
www.manakoa.com
7203 West Deschutes Avenue, Suite B
Kennewick, WA 99336 USA
Advanced ID Corporation
Dan Finch, President and CEO
(403) 252-7984
Fax: (403) 263-2055
danf@advancedidcorp.com
(C) 2006 PRIMEZONE, All rights reserved.
Hello, anybody here. You guys got news.
Stop by and check out you comrads in arms- Machinetalker.
http://biz.yahoo.com/pz/060926/105765.html
http://www.investorshub.com/boards/board.asp?board_id=5152
Gentleman Jim
this is heading to .25!
Moving up steadily.
Any thoughts?
Certainly will pump and dump tipsters getting ready on this one. IMHO.
this board will get busier!
I think we could see .22-.25 in the next week or so! a double from here!